ACRV

Acrivon Therapeutics (ACRV)

Acrivon Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ACRV

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/09/16	19:43	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/09/14	16:10	GlobeNewswire Inc.	Acrivon Therapeutics Reports Positive Endometrial Cancer Data from Ongoing ACR-368 Registrational Intent Phase 2 Study at ESMO, Advancement of ACR-2316 into Clinic Ahead of Timelines, and Progress on its AP3 Interactome for Proprietary Data Analysis	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/09/10	21:00	GlobeNewswire Inc.	Acrivon Therapeutics to Present at the Cantor Global Healthcare Conference	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/09/09	20:00	GlobeNewswire Inc.	Acrivon Therapeutics to Host Virtual Investor Event to Review Positive Phase 2 Clinical Data of ACR-368 Presented at ESMO and Pipeline Progress, Including Clinical Candidate ACR-2316	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/08/24	05:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/08/17	05:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/08/17	05:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/08/17	05:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/08/17	05:51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/08/17	05:50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/08/17	05:48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/08/17	05:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/08/13	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/08/13	21:00	GlobeNewswire Inc.	Acrivon Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/08/13	20:36	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/07/20	05:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/05/29	21:00	GlobeNewswire Inc.	Acrivon Therapeutics to Present at the Jefferies Global Healthcare Conference	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/05/22	05:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/05/17	08:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/05/17	08:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/05/17	08:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/05/17	08:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/05/17	07:58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/05/17	07:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/05/17	07:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/05/17	07:52	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/05/14	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/05/14	21:00	GlobeNewswire Inc.	Acrivon Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/05/14	20:31	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ACRV	Acrivon Therapeutics Inc
2024/04/25	05:01	GlobeNewswire Inc.	Acrivon Therapeutics Reports Initial Positive Clinical Data for ACR-368 and Pipeline Program Progress Today at Corporate R&D Event	NASDAQ:ACRV	Acrivon Therapeutics Inc